Table 8. Plasma creatinine, BUN, lipase, ALT and AST levels at the end of treatment.
Treatment | Creatinine (mg/dL) | BUN (mg/dL) | Lipase (U/L) | ALT (U/L) | AST (U/L) |
Lean Veh | 0.32±0.01 | 18.5±0.7 | 76±12 | 54±14* | 64±6* |
DIO Veh | 0.35±0.01 | 16.1±0.9 | 86±2 | 125±11 | 106±12 |
CB1 ASO 25 mg/kg/wk | 0.33±0.00 | 14.9±0.9 | 70±4 | 80±6* | 103±12 |
CB1 ASO 12.5 mg/kg/wk | 0.36±0.02 | 17.5±1.5 | 89±5 | 122±10 | 138±32 |
CB1 ASO 6.25 mg/kg/wk | 0.33±0.01 | 15.9±0.3 | 97±10 | 103±15 | 85±9 |
Control ASO 25 mg/kg/wk | 0.47±0.13 | 17.1±0.3 | 90±2 | 73±7* | 71±5* |
Values shown are mean ± se. One way ANOVA Dunnett’s multiple test compared to DIO Veh, *p<0.05.